127 related articles for article (PubMed ID: 16465783)
21. Human papillomavirus: its identity and controversial role in oral oncogenesis, premalignant and malignant lesions (review).
Campisi G; Panzarella V; Giuliani M; Lajolo C; Di Fede O; Falaschini S; Di Liberto C; Scully C; Lo Muzio L
Int J Oncol; 2007 Apr; 30(4):813-23. PubMed ID: 17332919
[TBL] [Abstract][Full Text] [Related]
22. Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.
Syrjänen KJ
Scand J Infect Dis Suppl; 2009; 107():3-32. PubMed ID: 19408160
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus infection and the development of cervical cancer and related genital neoplasias.
Paavonen J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S3-9. PubMed ID: 18162244
[TBL] [Abstract][Full Text] [Related]
24. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions.
Hubert P; Caberg JH; Gilles C; Bousarghin L; Franzen-Detrooz E; Boniver J; Delvenne P
J Pathol; 2005 Jul; 206(3):346-55. PubMed ID: 15852499
[TBL] [Abstract][Full Text] [Related]
25. Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix.
Delvenne P; Herman L; Kholod N; Caberg JH; Herfs M; Boniver J; Jacobs N; Hubert P
Mol Cell Endocrinol; 2007 Jan; 264(1-2):1-5. PubMed ID: 17145130
[TBL] [Abstract][Full Text] [Related]
26. Role of IL-10 in immune suppression in cervical cancer.
Bhairavabhotla RK; Verm V; Tongaonkar H; Shastri S; Dinshaw K; Chiplunkar S
Indian J Biochem Biophys; 2007 Oct; 44(5):350-6. PubMed ID: 18341210
[TBL] [Abstract][Full Text] [Related]
27. MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer.
Segat L; Crovella S; Comar M; Milanese M; Zanotta N; Fabris A; Trevisiol C; Rossi T; De Seta F; Campello C
Hum Immunol; 2009 Jun; 70(6):436-9. PubMed ID: 19275921
[TBL] [Abstract][Full Text] [Related]
28. Natural history and epidemiology of HPV infection and cervical cancer.
Castellsagué X
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
[TBL] [Abstract][Full Text] [Related]
29. The role of retinoid deficiency and estrogens as cofactors in cervical cancer.
Gariglio P; Gutiérrez J; Cortés E; Vázquez J
Arch Med Res; 2009 Aug; 40(6):449-65. PubMed ID: 19853185
[TBL] [Abstract][Full Text] [Related]
30. [Prophylactic and therapeutic vaccination against human papillomavirus].
Brun JL; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2007 Nov; 36(7):631-41. PubMed ID: 17822860
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus vaccines for the treatment of cervical cancer.
Sin JI
Expert Rev Vaccines; 2006 Dec; 5(6):783-92. PubMed ID: 17184217
[TBL] [Abstract][Full Text] [Related]
32. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
Ivanov S
Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus vaccine: the beginning of the end for cervical cancer.
Bornstein J
Isr Med Assoc J; 2007 Mar; 9(3):156-8. PubMed ID: 17402325
[TBL] [Abstract][Full Text] [Related]
34. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
[TBL] [Abstract][Full Text] [Related]
35. Identification of human papillomavirus type 16 integration sites in high-grade precancerous cervical lesions.
Matovina M; Sabol I; Grubisić G; Gasperov NM; Grce M
Gynecol Oncol; 2009 Apr; 113(1):120-7. PubMed ID: 19157528
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the occurrence of torque tenovirus in malignant and potentially malignant disorders associated with human papillomavirus.
Fehér E; Gáll T; Murvai M; Kis A; Boda R; Sápy T; Tar I; Gergely L; Szarka K
J Med Virol; 2009 Nov; 81(11):1975-81. PubMed ID: 19774682
[TBL] [Abstract][Full Text] [Related]
37. Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles.
Bontkes HJ; Ruizendaal JJ; Kramer D; Meijer CJ; Hooijberg E
Gynecol Oncol; 2005 Mar; 96(3):897-901. PubMed ID: 15721448
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitination in host immune response to human papillomavirus infection.
Zhou Q; Zhu K; Cheng H
Arch Dermatol Res; 2011 May; 303(4):217-30. PubMed ID: 21400034
[TBL] [Abstract][Full Text] [Related]
39. Human Leukocyte Antigen-G (HLA-G) Expression in Precancerous and Cancerous Cervical Lesions: Association with Human Papilloma Virus Infection and Host Immune Response.
Fahim NM; Shehata IH; Taha SE; Fahmy RA; Elsayed MS
Egypt J Immunol; 2018 Jan; 25(1):125-134. PubMed ID: 30243004
[TBL] [Abstract][Full Text] [Related]
40. [Virus and cancer].
Gariglio P; Rangel LM
Salud Publica Mex; 1992; 34(3):308-17. PubMed ID: 1319613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
